PDI, Medical Affairs Form Strategic Alliance

PDI, a provider of sales and marketing support to US pharmaceutical companies, and The Medical Affairs Company, provider of customized medical science laison and medical affairs services, have signed an agreement aligning their respective services in order to bring a more complete set of field-based commercialization solutions.

Under the agreement, PDI and TMAC will integrate their service offerings to benefit client brands, participate in joint client presentations and exchange new business leads. By operating under this agreement, both PDI and TMAC are better able to meet client requirements, while preserving the separation of pharmaceutical sales and medical departments.

Nancy Lurker, CEO of PDI, said: The MSL plays an increasingly crucial role in pharmaceuticals today – that of providing high-level scientific information to key opinion leaders and other medical doctors on a peer-to-peer basis. We’re very pleased to partner with TMAC through this strategic alliance. TMAC’s expertise in providing MSL services to pharmaceutical companies is highly regarded. Our agreement increases PDI’s ability to provide maximum value to our clients and fills a critical need for a higher science personal engagement with physicians.